Study: Progesterone protects the brain during stroke

By Jan Jarvis

Meharvan Sonny Singh

 

HSC Insider

Learn more about UNTHSC’s people and programs by signing up for the weekly HSC Insider email.

Time is critical when someone has a stroke – especially the first three to four hours.

That’s how long someone has to get to the hospital for treatment with the only clot-busting drug that can save lives and reduce disability. But all too often people never make it in time, said Meharvan Singh, PhD, Professor of Pharmacology & Neuroscience.

“What happens is people feel like they have the worst headache of their life, so they might go to bed and try to sleep it off,” he said. “Even if they do recognize their symptoms as that of a stroke, by the time they get to the hospital they will have likely missed that window for treatment.”

Dr. Singh and a team of researchers want to expand that window. They have developed a novel therapeutic strategy to help the brain heal and improve the odds of recovery for the nearly 800,000 people who have a stroke annually.

In a study published in The Proceedings of the National Academy of Sciences, Dr. Singh and his colleagues, Dr. Trinh Nguyen and Chang Su report on the role of miRNA let-7i in regulating the protective function of the female hormone progesterone in stroke. MicroRNAs are small RNA molecules that are expressed endogenously and play an important role in regulating gene expression.

Dr. Singh’s team found that by inhibiting let-7i, the protective efficacy of progesterone was greatly enhanced, evidenced by greatly reduced ischemic stroke injury and the complete recovery of motor function.

“By inhibiting miRNA let-7i we helped make the brain responsive to the protective effects of progesterone, as it should be,” he said. “Progesterone had a remarkable effect.”

The hope is that one day the research will be translated into a viable treatment for people who have a stroke. There is a critical need for better treatments for stroke since the only approved drug has a limited window of opportunity.

When an ischemic stroke occurs, blood flow to the brain is interrupted and the area affected dies. Since the brain is unable to repair itself, stroke can lead to death or cause long-term disability. Stroke is the fifth leading cause of death and a major cause of disability in the United States, costing approximately $34 billion annually.

Dr. Singh said the work was a team effort among faculty and students in the Graduate School of Biomedical Sciences.

“I certainly am thrilled to be able to report on this research,” he said. “But I’m also happy to share this success as an example of the innovative and highly relevant work our students are doing.”

Recent News

Stephanie Ibekwe
  • Our People
|Dec 5, 2022

A voice for women in medicine

When Dr. Stephanie Ibekwe’s mother, Sarah, came home from her nursing job, she would tell her daughter stories about her patients and the conversations she had with them. “Nursing is pretty stressful, but my mom had an amazing way of handling things,” she said. “My mom really loved to bui...
Noah Peeri Headshot
  • Our People
|Dec 5, 2022

SPH alum Dr. Noah Peeri produces JAMA Oncology publication just months after graduation

Noah Peeri, Ph.D., MPH, a recent graduate of The University of North Texas Health Science Center’s School of Public Health, has achieved a major milestone by publishing an article in the Journal of the American Medical Association Oncology just months after completing his graduate degree.   H...
Techstars Demo Day.
  • On Campus
|Dec 1, 2022

Techstars Demo Day brings innovation to the historic stockyards

For the last 13 weeks, the founders of 10 of the world’s most innovative startups have been in Fort Worth perfecting their new physical health technology. They are part of the world’s first physical health accelerator, and now they are ready to show the fruits of their labor. Techstars Demo D...
Dr. Sid O'bryant Award
  • Our People
|Dec 1, 2022

HSC named the winner of the D Magazines 2022 Achievement in Medical Research Award

The extensive research done by Dr. Sid O’Bryant and his team at the Institute of Translational Research has earned the University of North Texas Health Science Center at Fort Worth the 2022 Medical Research Award by D Magazine. Dr. O’Bryant, the executive director of the ITR and a professor at t...